Cargando…

P009 The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease

INTRODUCTION: Low-dose morphine is prescribed for refractory breathlessness in chronic obstructive pulmonary disease (COPD). Preliminary investigations suggest improved perceived sleep quality, although concerns exist regarding opioid-induced sedation. This study assessed the effects of morphine on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altree, T, Loffler, K, Toson, B, Currow, D, Eckert, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109289/ http://dx.doi.org/10.1093/sleepadvances/zpac029.082

Ejemplares similares

P066 The Relationship between Chronic Breathlessness and Perceived Sleep Quality in Adult Australian
por: Toson, B, et al.
Publicado: (2023)

O001 Reboxetine reduces obstructive sleep apnea severity: a randomized trial
por: Altree, T, et al.
Publicado: (2021)

P001 Safety, tolerability, and efficacy of 1 month of atomoxetine plus oxybutynin in obstructive sleep apnoea
por: Aishah, A, et al.
Publicado: (2021)

P154 Upper Airway Sensation in Obstructive Sleep Apnea - A Systematic Review and Meta-Analysis to Inform Pathogenesis, Treatment and Future Research
por: Wallace, E, et al.
Publicado: (2021)

P002 Targeted non-CPAP combination therapy resolves obstructive sleep apnoea
por: Aishah, A, et al.
Publicado: (2021)

Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial
por: Janowiak, Piotr, et al.
Publicado: (2017)

P087 Exploring Associations between, and Temporal Changes in, the Sleep, Psychological Affect, and Exercise Performance of Elite Cyclists during a period containing the Tour de France
por: Fitton, J, et al.
Publicado: (2023)

Patients’ and their caregivers’ experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study
por: Ferreira, Diana, et al.
Publicado: (2022)

A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol
por: Currow, David, et al.
Publicado: (2017)

Chronic breathlessness and sleep problems: a population-based survey
por: Currow, David C, et al.
Publicado: (2021)

Regular, low-dose methadone for reducing breathlessness in people experiencing or at risk of neurotoxic effects from morphine: A single-center case series
por: Sobanski, Piotr Z., et al.
Publicado: (2022)

Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol
por: Date, Kathryn, et al.
Publicado: (2023)

P074 Night-to-night variability in obstructive sleep apnoea severity is associated with hypertension and high misdiagnosis rates
por: Lechat, B, et al.
Publicado: (2021)

Narratives of breathlessness in chronic obstructive pulmonary disease
por: Kvangarsnes, Marit, et al.
Publicado: (2013)

P009 Australian consultant pharmacists’ potential roles in sleep health care - Exploring a new avenue for improving the management of insomnia
por: Basheti, M, et al.
Publicado: (2021)

P019 Obstructive sleep apnoea endotypes in people with multiple sclerosis
por: Carter, S, et al.
Publicado: (2021)

P018 The effects of zopiclone on sleep spindles in obstructive sleep apnea: A randomized placebo-controlled trial
por: Carter, S, et al.
Publicado: (2021)

Persistent disabling breathlessness in chronic obstructive pulmonary disease
por: Sundh, Josefin, et al.
Publicado: (2016)

How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease
por: Lewthwaite, Hayley, et al.
Publicado: (2021)

P155 Effects of upper airway muscle training on upper airway physiology in people with obstructive sleep apnea
por: Wallace, E, et al.
Publicado: (2021)

Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo‐controlled trial
por: Johnson, Miriam J., et al.
Publicado: (2019)

Assessments of patients' Experiences of breathlessness during a spontaneous breathing trial
por: Haugdahl, HS, et al.
Publicado: (2015)

Sleep disturbances in a Canadian population with asthma or chronic obstructive pulmonary disease (COPD)
por: Cormiers, A Des, et al.
Publicado: (2010)

P009. A case of new daily persistent headache treated with botulinum toxin type A
por: Trucco, Marco, et al.
Publicado: (2015)

P009 Time spent with SpO2 below 90% during Sleep is Greater in Children with Down syndrome and OSA than in Typically Developing Children
por: Walter, L, et al.
Publicado: (2023)

Two faces of the same coin: a qualitative study of patients’ and carers’ coexistence with chronic breathlessness associated with chronic obstructive pulmonary disease (COPD)
por: Ferreira, Diana H., et al.
Publicado: (2020)

Retracted: P093 Chronic Obstructive Pulmonary Disease – Obstructive Sleep Apnoea Overlap Syndrome – Prevalence in a Home ventilation service
por: Rajagopalan, P
Publicado: (2022)

The effect of volitional breathing on the breathlessness-ventilation relationship during progressive exercise in healthy subjects
por: Reed, JW, et al.
Publicado: (2001)

P009: Epidemiology, microbiology and outcome of community-οnset gram-negative bacteremias in a Greek University Hospital
por: Gikas, A, et al.
Publicado: (2013)

Influence of age on the distribution of morphine and morphine-3-glucuronide across the blood–brain barrier in sheep
por: Ederoth, P, et al.
Publicado: (2009)

P004 Addition of an oral expiratory positive pressure valve (EPAP) to an oral appliance therapy device can resolve obstructive sleep aponea (OSA)
por: Aishah, A, et al.
Publicado: (2022)

P073 Co-morbid insomnia and obstructive sleep apnoea is associated with all-cause mortality and cardiovascular event risk
por: Lechat, B, et al.
Publicado: (2021)

Predictors of chronic breathlessness: a large population study
por: Bowden, Jacqueline A, et al.
Publicado: (2011)

Adding ultralow-dose oral naltrexone to morphine: a double-blind, randomized clinical trial
por: Farahmand, S, et al.
Publicado: (2010)

P-009: IDENTIFYING BARRIERS FOR PATIENTS WITH SICKLE CELL DISEASE TO ACCESS TREATMENT WITH HYDROXYUREA – A QUALITATIVE ANALYSIS OF THE SUPPLY CHAIN IN GHANA
por: S., GRAVEN, et al.
Publicado: (2022)

Diastolic function abnormalities in ICU patients with chronic obstructive pulmonary disease
por: Michalopoulou, H, et al.
Publicado: (2008)

Retracted: P094 Sleep quality assessment among Chronic Obstructive Pulmonary Disease patients in a tertiary teaching hospital
por: Rajagopalan, P
Publicado: (2022)

Breathlessness Beliefs and Related Factors in Male Patients with Chronic Obstructive Pulmonary Disease
por: Bayraktar, Deniz, et al.
Publicado: (2023)

P143 Sleep-dependent declarative memory consolidation and NREM sleep EEG oscillations in older adults with obstructive sleep apnea
por: Teh, J, et al.
Publicado: (2021)

P109 The association between sleep microarchitecture and cognitive function in middle-aged and older men: A community-based study
por: Parker, J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_35refl0gpifo9em0j167qipker